Study CLBP-2: Four hundred and four patients were randomized to receive fixed dosages of CYMBALTA daily or a matching placebo (N=59 on CYMBALTA 20 mg, N=116 on CYMBALTA 60 mg, N=112 on CYMBALTA 120 mg, N=117 on placebo) and 267 (66%) completed the entire 13-week trial
There are ongoing studies for these uses, but early data are weak and the risks are unknown
[DOI] [PubMed] [Google Scholar] 51.Merlo FD, Aimasso U, Ossola M, et al
Ideal para todos los tipos de piel, Aox Glutathione proporciona un enfoque integral para retrasar los signos del envejecimiento, apoyando la salud y la apariencia juvenil de la piel desde el interior
Five deaths occurred across the trial, with one heart-failure death in a participant receiving zalfermin alone considered possibly related to study drug
The Cleveland Clinic notes collagen is ubiquitous in the body and outlines the major collagen types and roles